Detalhe da pesquisa
1.
[Well Differentiated Liposarcoma of a Lung:Report of a Case].
Kyobu Geka
; 77(3): 230-234, 2024 Mar.
Artigo
em Japonês
| MEDLINE | ID: mdl-38465498
2.
Diagnostic significance of secondary bacteremia in patients with COVID-19.
J Infect Chemother
; 29(4): 422-426, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-36682606
3.
Impact of respiratory bacterial infections on mortality in Japanese patients with COVID-19: a retrospective cohort study.
BMC Pulm Med
; 23(1): 146, 2023 Apr 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-37101265
4.
[Outcomes of COVID-19 due to omicron variant infection complicated with hematological disorders].
Rinsho Ketsueki
; 64(1): 3-8, 2023.
Artigo
em Japonês
| MEDLINE | ID: mdl-36775303
5.
[Endobronchial Hamartoma Treated with Bronchoscopic Microwave Tissue Coagulation and Electrosurgical Snaring:Report of a Case].
Kyobu Geka
; 76(2): 168-171, 2023 Feb.
Artigo
em Japonês
| MEDLINE | ID: mdl-36731856
6.
Most Important Things and Associated Factors With Prioritizing Daily Life in Patients With Advanced Lung Cancer.
JCO Oncol Pract
; 18(12): e1977-e1986, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36346964
7.
Long-term Survival of a Patient with Small Cell Lung Cancer Secreting ADH and ACTH Simultaneously, Following the Prolonged Use of Amrubicin.
Intern Med
; 59(1): 107-112, 2020 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31511478
8.
Overcoming EGFR Bypass Signal-Induced Acquired Resistance to ALK Tyrosine Kinase Inhibitors in ALK-Translocated Lung Cancer.
Mol Cancer Res
; 15(1): 106-114, 2017 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27707887
9.
Erlotinib as second- or third-line treatment in elderly patients with advanced non-small cell lung cancer: Keio Lung Oncology Group Study 001 (KLOG001).
Mol Clin Oncol
; 6(3): 409-414, 2017 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-28451422
10.
Activation of EGFR Bypass Signaling by TGFα Overexpression Induces Acquired Resistance to Alectinib in ALK-Translocated Lung Cancer Cells.
Mol Cancer Ther
; 15(1): 162-71, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26682573
11.
In vitro modeling to determine mutation specificity of EGFR tyrosine kinase inhibitors against clinically relevant EGFR mutants in non-small-cell lung cancer.
Oncotarget
; 6(36): 38789-803, 2015 Nov 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-26515464